About the Cardio Metabolic Unit (CMU)
CMU is a constellation of researchers dedicated to advancing the prevention, diagnosis, and treatment of cardiometabolic diseases, including dyslipidemia, atherosclerosis, diabetes, and metabolic-associated fatty liver disease.
Our interdisciplinary teams combine expertise in molecular biology, biochemistry, genomics, hepatology, lipidology, cardiology, endocrinology, and systems medicine to drive innovative research and collaborative breakthroughs. We explore molecular mechanisms, genetic factors, and novel therapeutic approaches, often partnering with industry to push the boundaries of cardiometabolic research.
Commitment to CoARA
CMU adheres to the principles, ensuring that our research practices are transparent, responsible, and aligned with best practices in research assessment. We believe that this commitment enhances the quality and impact of our outreach efforts.
Grants
2024
- dAIbetes - EU Horizon Project – Paolo Parini
- The Rolf Luft Grant for Instrumentation – Paolo Parini
2023
- REPO – Paolo Parini 
- Vinnova – Paolo Parini
- VR – Paolo Parini